Lv11
16 积分 2021-05-12 加入
Trends in target novelty in oncology R&D
2小时前
求助中
Graves disease: latest understanding of pathogenesis and treatment options
1天前
已完结
Molecular intelligence and immune reconnaissance in thyroid cancer: a new paradigm for diagnosis, risk stratification, and therapeutic precision
1天前
已完结
TL1A blockade in inflammatory bowel diseases: Clinical trials to watch
2天前
求助中
Biomarker-driven strategies and challenges in acute graft-versus-host disease clinical trials
3天前
已完结
CXCR6 as a novel therapeutic target in allergic asthma
4天前
已完结
Large‐Scale Blood Proteomic Analysis Across Different Inflammatory Skin Conditions Reveals Extensive Immune Dysregulation With Distinct Biomarker Profiles
4天前
已完结
New age GVHD prophylaxis regimens: what works for what donor and why
11天前
已关闭
CAR T-cell therapy and bispecific antibodies in the management of multiple myeloma
11天前
已关闭
Facts and hopes in harnessing macrophage-mediated antibody-dependent cellular phagocytosis for cancer immunotherapy
14天前
已完结
The metabolic foibles of triple negative breast cancer
皖公网安备34019202002308
